Vinpohasco

Package Leaflet: Information for the Patient

VinpoHasco

5 mg, tablets

Vinpocetine

Read the package leaflet carefully before taking the medicine, as it contains important information for the patient.

• Keep this leaflet, you may need to read it again.
• If you have any further questions, ask your doctor, pharmacist, or nurse.
• This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
• If you experience any side effects, including those not listed in this leaflet, tell your doctor, pharmacist, or nurse. See section 4.

Table of Contents of the Leaflet

• 1. What is VinpoHasco and what is it used for
• 2. Important information before taking VinpoHasco
• 3. How to take VinpoHasco
• 4. Possible side effects
• 5. How to store VinpoHasco
• 6. Contents of the pack and other information

1. What is VinpoHasco and what is it used for

The active substance of VinpoHasco is vinpocetine. Vinpocetine is a compound used in the treatment of diseases or alleviation of symptoms related to blood circulation disorders in the brain.
VinpoHasco is used in:

• treatment of mental and neurological symptoms of cerebral circulatory insufficiency,
• treatment of chronic circulatory disorders in the vascular and retinal tissues of the eye,
• treatment of hearing disorders of vascular origin.

2. Important information before taking VinpoHasco

When not to take VinpoHasco:

• if you are allergic to the active substance or any of the other ingredients of this medicine (listed in section 6),
• in acute coronary heart disease and severe cardiac arrhythmias,
• in the acute phase of hemorrhagic stroke,
• during pregnancy and breastfeeding,
• in children due to the lack of sufficient clinical trials in this age group.

Warnings and precautions

Before starting treatment with VinpoHasco, discuss it with your doctor, pharmacist, or nurse.
During long-term treatment, monitor blood biochemical parameters.
It is recommended to control the ECG recording in case of prolonged QT interval syndrome (changes in the electrocardiogram) or taking additional medication that causes QT interval prolongation.
You should consult a doctor, even if the above warnings concern situations that occurred in the past.

Taking VinpoHasco in patients with kidney and/or liver function disorders

No dose adjustment is recommended in patients with kidney or liver disease.

Taking VinpoHasco in elderly patients

No dose adjustment is recommended in elderly patients.

VinpoHasco and other medicines

Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
In individual cases, vinpocetine enhances the hypotensive (blood pressure lowering) effect of α-methyldopa, so during such combined therapy, regular blood pressure monitoring is recommended.
Caution should be exercised when taking vinpocetine in combination with drugs acting on the central nervous system, as well as with antiarrhythmic (drugs used in cardiac arrhythmias) and anticoagulant (drugs reducing blood clotting) medications, and with glibenclamide (a drug used in diabetes).

VinpoHasco with food and drink

The medicine should be taken after a meal.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, ask your doctor or pharmacist for advice before taking this medicine.
VinpoHasco is contraindicated during pregnancy and breastfeeding.

Driving and using machines

There is no data on the effect of vinpocetine on the ability to drive and use machines.

VinpoHasco contains lactose

If you have been diagnosed with intolerance to some sugars, you should contact your doctor before taking the medicine.

3. How to take VinpoHasco

This medicine should always be taken exactly as advised by your doctor or pharmacist. If you are unsure, ask your doctor or pharmacist.
The usual dose is:
Adults: 1-2 tablets (5 to 10 mg) 3 times a day.
Maintenance dose: 1 tablet (5 mg) 3 times a day.
The medicine should be taken after a meal.
If you feel that the effect of VinpoHasco is too strong or too weak, consult your doctor.

Taking more VinpoHasco than recommended

If you have taken more than the recommended dose, consult your doctor or pharmacist.
There is no data on overdose.

Missing a dose of VinpoHasco

Do not take a double dose to make up for a missed dose.

4. Possible side effects

Like all medicines, VinpoHasco can cause side effects, although not everybody gets them.
Reported side effects:
Uncommon(in 1 to 10 patients per 1000):

• sleep disorders (insomnia, drowsiness), dizziness, and headaches, weakness,
• blood pressure changes (mainly blood pressure decrease), flushing,
• nausea, heartburn, and dry mouth,
• increased liver enzyme activity,
• allergic skin reactions,
• changes in the electrocardiogram (depression of the ST segment, prolongation of the QT interval, tachycardia, and extrasystole - these symptoms subsided spontaneously, and therefore, it is not certain whether they were caused by vinpocetine).

Rare(in 1 to 10 patients per 10,000):

• abdominal pain,
• leukopenia (decreased white blood cell count).

Reporting side effects

If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Aleje Jerozolimskie 181C, 02-222 Warsaw
tel.: +48 22 49 21 301, fax: +48 22 49 21 309
e-mail: ndl@urpl.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store VinpoHasco

Store in the original package, at a temperature below 25°C.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the package. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

What VinpoHasco contains

• The active substance is vinpocetine. One tablet contains 5 mg of vinpocetine.
• The other ingredients are: lactose monohydrate, microcrystalline cellulose, sodium carboxymethylcellulose (type A), magnesium stearate, anhydrous colloidal silica.

What VinpoHasco looks like and contents of the pack

The medicine is a white, round, flat, smooth tablet.
One pack of VinpoHasco contains 50 or 100 tablets.

Marketing authorization holder and manufacturer

“HASCO-LEK” Pharmaceutical Company S.A.
51-131 Wrocław, ul. Żmigrodzka 242 E

Information about the medicine

tel.: 22 742 00 22
e-mail: informacjaoleku@hasco-lek.pl

Date of last revision of the leaflet: